相似文献
1
Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Br J Cancer. 1995 Nov;72(5):1241-4. doi: 10.1038/bjc.1995.493.
2
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer.
Br J Cancer. 1996 Nov;74(10):1615-9. doi: 10.1038/bjc.1996.597.
3
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eur J Cancer. 1998 Dec;34(13):2076-81. doi: 10.1016/s0959-8049(98)00241-x.
4
Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.
Genes Chromosomes Cancer. 1995 Aug;13(4):291-4. doi: 10.1002/gcc.2870130410.
5
Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Clin Endocrinol (Oxf). 1996 Aug;45(2):195-200. doi: 10.1046/j.1365-2265.1996.d01-1561.x.
6
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
J Med Genet. 2000 May;37(5):342-7. doi: 10.1136/jmg.37.5.342.
7
Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
Cancer Res. 1996 May 1;56(9):1988-90.
8
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Oncogene. 1995 Apr 20;10(8):1673-5.
9
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
Cancer Res. 1995 Nov 1;55(21):4830-2.
10
Overexpression of BRCA2 gene in sporadic breast tumours.
Oncogene. 1999 Sep 16;18(37):5232-8. doi: 10.1038/sj.onc.1202903.
引用本文的文献
1
Significance of and Co-loss in Aggressive Prostate Cancer Progression.
Clin Cancer Res. 2020 Apr 15;26(8):2047-2064. doi: 10.1158/1078-0432.CCR-19-1570. Epub 2019 Dec 3.
2
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in -Associated Prostate Cancer Resulting From Biallelic Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.
JCO Precis Oncol. 2018;2. doi: 10.1200/PO.17.00176. Epub 2018 Feb 14.
3
Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectives.
Mol Genet Genomic Med. 2018 Nov;6(6):957-965. doi: 10.1002/mgg3.464. Epub 2018 Oct 11.
4
Post-transcriptional Regulation of BRCA2 through Interactions with miR-19a and miR-19b.
Front Genet. 2016 Aug 31;7:143. doi: 10.3389/fgene.2016.00143. eCollection 2016.
5
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.
BMC Syst Biol. 2015 Sep 21;9:62. doi: 10.1186/s12918-015-0211-x.
6
Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.
Br J Cancer. 2014 Dec 9;111(12):2351-60. doi: 10.1038/bjc.2014.511.
7
ATR inhibition preferentially targets homologous recombination-deficient tumor cells.
Oncogene. 2015 Jun;34(26):3474-81. doi: 10.1038/onc.2014.276. Epub 2014 Sep 1.
8
Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013 May 2;14(5):9536-55. doi: 10.3390/ijms14059536.
9
Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
J Clin Oncol. 2008 Nov 20;26(33):5393-400. doi: 10.1200/JCO.2008.17.8228. Epub 2008 Sep 29.
10
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.
J Clin Pathol. 2005 May;58(5):493-9. doi: 10.1136/jcp.2004.020388.
本文引用的文献
1
Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Cancer Res. 1994 Feb 1;54(3):610-3.
2
3
Instability of short tandem repeats (microsatellites) in human cancers.
Nat Genet. 1994 Feb;6(2):152-6. doi: 10.1038/ng0294-152.
4
Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.
Br J Cancer. 1994 Aug;70(2):255-62. doi: 10.1038/bjc.1994.289.
5
Recent developments in the molecular genetic understanding of breast cancer.
Crit Rev Oncog. 1994;5(2-3):247-70. doi: 10.1615/critrevoncog.v5.i2-3.70.
6
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Oncogene. 1995 Apr 20;10(8):1673-5.
7
The 1993-94 Généthon human genetic linkage map.
Nat Genet. 1994 Jun;7(2 Spec No):246-339. doi: 10.1038/ng0694supp-246.
8
Allelotype of head and neck paragangliomas: allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL.
Genes Chromosomes Cancer. 1994 Oct;11(2):71-8. doi: 10.1002/gcc.2870110202.
9
Inactivation of the retinoblastoma susceptibility gene in human breast cancers.
Science. 1988 Jul 8;241(4862):218-21. doi: 10.1126/science.3388033.
10
Structural rearrangement of the retinoblastoma gene in human breast carcinoma.
Science. 1988 Oct 14;242(4876):263-6. doi: 10.1126/science.3175651.
Zotero 插件